С. М. Ситдикова

ORCID: 0000-0002-2840-1186
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunotherapy and Immune Responses
  • Drug Transport and Resistance Mechanisms
  • Toxin Mechanisms and Immunotoxins
  • Cancer Cells and Metastasis
  • Monoclonal and Polyclonal Antibodies Research
  • Computational Drug Discovery Methods
  • Cancer Immunotherapy and Biomarkers
  • Mesenchymal stem cell research
  • Hemoglobin structure and function
  • Melanoma and MAPK Pathways
  • Immune Response and Inflammation
  • Estrogen and related hormone effects
  • Glycosylation and Glycoproteins Research
  • Antimicrobial Peptides and Activities
  • Lung Cancer Treatments and Mutations
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Cancer Research and Treatments
  • Ferroptosis and cancer prognosis
  • Microbial infections and disease research
  • Mathematical Biology Tumor Growth
  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Protein purification and stability

Ministry of Health of the Russian Federation
2017-2021

Russian Cancer Research Center NN Blokhin
2006-2017

Academy of Medical Sciences
1993-2011

Russian Academy of Sciences
1993-2011

Cancer Research Center
1993-2006

Non-degradable steel and titanium implants used to replace defects of the locomotor system or fabricate vascular stents provide maximum stability but have too many drawbacks.Currently, biodegradable magnesium alloys are considered as promising materials for creation fixation devices in orthopedics cardiovascular surgery.First attempts using magnesium-based bone were made early at beginning 20 th century, however, due a high corrosion rate gas formation they turned out be...

10.17691/stm2019.11.3.18 article EN Sovremennye tehnologii v medicine 2019-09-01

In the present study, we analyzed differential composition of blood serum from Ehrlich carcinoma-bearing and healthy male C57Bl/6 mice by isolating complexes hemoglobin other proteins a proteomic approach (gel filtration, gel electrophoresis, mass spectrometry). The fractions isolated mice- bearing tumors contained several with molecular weights 15, 65, 68, 100 kDa, while did not contain additional protein bands. These bands were identified MALDI-TOF as haptoglobin, albumin, homologue...

10.3892/ijo.32.4.885 article EN International Journal of Oncology 2008-04-01

Literature review is devoted to immunosuppression in sepsis and possibilities of its correction.

10.24884/0042-4625-2018-177-5-105-107 article EN cc-by Grekov s Bulletin of Surgery 2018-11-23

Introduction. Results of the systemic chemotherapy in peritoneum canceromatosis are unsatisfactory because poor penetration anticancer drugs serous cavities due to presence ofperitoneal-plasma barrier. One possible ways enhance action cytostatic agents is use and hyperthermia, which, according some data, has an own cytotoxic effect. The purpose study. study effect ofdifferent modes hyperthermia on physiological activity transplantable lines tumor non-transformed cells. Results. Analysis...

10.18821/1028-9984-2016-21-5-250-252 article EN Russian Journal of Oncology 2016-10-15

Immune checkpoint inhibitors (ICT) therapy is a successful immunotherapy (IT) strategy that quite effective in number of patients with non-small cell lung cancer, melanoma, bladder breast cancer and others. Nevertheless, there need predictive markers for ICT personalized IT as far large group patients, the proportion which varies depending on tumor, who do not have clinical response to such therapy. The review summarizes theoretical aspects results trials dedicated various efficiency...

10.21682/2311-1267-2021-8-2-73-83 article EN Russian Journal of Pediatric Hematology and Oncology 2021-07-12

Введение.В рамках конструирования молекул с патогенетической направленностью к опухолевой клетке создан ряд химерных пептидов, включающих функциональный фрагмент аминокислотной последовательностью из группы SEQ ID NO: 1 -SEQ 17 и транспортную последовательность.Эти пептиды при целевой доставке в клетку способны обнаруживать короткие функциональные домены белках-регуляторах различных функций.Среди них ММ-D37K, блокирующий фазу G1 индуцирующий апоптоз клетках опухолей человека, том числе...

10.17650/1726-9784-2017-16-2-36-41 article RU cc-by Russian Journal of Biotherapy 2017-06-30

Введение. Разработка новых моделей диссеминированной меланомы кожи человека с наличием молекулярно-генетической мишени для таргетной терапии повышает результативность доклинических исследований in vitro и vivo антимеланомных средств их комбинаций. Такая возможность реализована путем адаптации к росту оригинальной линии клеток беспигментной mel Rac получению подкожного (п/к) ксенографта под контролем трансплантационных, морфологических, молекулярно-генетических (мутация NRAS)...

10.17650/1726-9784-2016-15-3-40-46 article RU cc-by Russian Journal of Biotherapy 2016-09-30

Introduction. Development of new models a human disseminated skin melanoma the with molecular-genetic targets for specific therapy increases productivity preclinical researches anti-melanoma drugs or their combinations in vitro and vivo. Such opportunity is realized by adaptation vivo original pigmented cell line mel Cher receiving subcutaneous (s. c.) xenograft under monitoring transplant, morphological, (V600E BRAF mutation) chemotherapeutic (sensitivity inhibitor kinases to vemurafenib)...

10.17650/1726-9784-2016-15-4-65-71 article EN cc-by Russian Journal of Biotherapy 2016-12-30

Введение.Разработка новых ортотопических моделей опухолевого роста (surgical orthotopic implantation, SOI) открывает возможность доклинического изучения потенциального антиметастатического действия препаратов, в том числе направленных на лечение диссеминированного светлоклеточного рака почки, с использованием качестве имплантата фрагмента опухоли или метастаза от пациента.Использование подкожного (п/к) ксенографта оптимизации SOI расширением возможностей применения эксперименте.Наличие п/к...

10.17650/1726-9784-2017-16-1-51-60 article RU cc-by Russian Journal of Biotherapy 2017-03-30
Coming Soon ...